[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

about

Tuberculosis treatment.

P2860

Q47558580-7EABB597-A950-468F-9602-5FC84BB18EFF

P2860

[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

Item

http://www.wikidata.org/entity/Q41176187

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

[Safe use of biological therap ...... itis and spondyloarthritides].

@en

type

Item

label

[Safe use of biological therap ...... itis and spondyloarthritides].

@en

prefLabel

[Safe use of biological therap ...... itis and spondyloarthritides].

@en

P1476

[Safe use of biological therap ...... itis and spondyloarthritides].

@en

P2093

Bóris Afonso Cruz

http://www.w3.org/2001/XMLSchema#string

Daniel Feldman Pollak

http://www.w3.org/2001/XMLSchema#string

Ieda Maria Magalhães Laurindo

http://www.w3.org/2001/XMLSchema#string

Ivânio Alves Pereira

http://www.w3.org/2001/XMLSchema#string

Jozélio Freire de Carvalho

http://www.w3.org/2001/XMLSchema#string

Licia Maria Henrique da Mota

http://www.w3.org/2001/XMLSchema#string

Luis Eduardo Coelho Andrade

http://www.w3.org/2001/XMLSchema#string

Manoel Barros Bertolo

http://www.w3.org/2001/XMLSchema#string

Marcelo de Medeiros Pinheiro

http://www.w3.org/2001/XMLSchema#string

Max Victor Carioca Freitas

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

Cellular targeting in autoimmunity

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

P2888

j.rbr.2014.06.006

P304

281-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RBR.2014.06.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Geraldo da Rocha Castelar Pinheiro

Claiton Viegas Brenol

Percival D Sampaio-Barros

P577

2014-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266857958

http://www.w3.org/2001/XMLSchema#string

P6179

1001317408

http://www.w3.org/2001/XMLSchema#string

P698

26054442

http://www.w3.org/2001/XMLSchema#string

[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

about

P2860

P2860

[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698